Table 3.
Trend of heart rate, systolic blood pressure, and diastolic blood pressure in the two groups
Time interval | Heart rate (beats/min) | SBP (mmHg) | DBP (mmHg) | ||||||
---|---|---|---|---|---|---|---|---|---|
Group P | Group E | P | Group P | Group E | P | Group P | Group E | P | |
Baseline (T0) | 86.27±14.12 | 86.37±13.43 | 0.978 | 128.40±24.77 | 130.40±24.99 | 0.757 | 74.60±11.75 | 77.07±9.99 | 0.385 |
Just after induction (T1) | 79.40±12.88 | 79.37±11.69 | 0.992 | 105.73±18.32 | 108.27±20.41 | 0.615 | 68.13±10.50 | 71.53±8.94 | 0.182 |
Just before ECT (T2) | 78.67±12.44 | 80.33±12.14 | 0.601 | 101.33±17.02 | 109.27±21.01 | 0.114 | 67.90±10.06 | 71.40±9.40 | 0.169 |
1 min after ECT (T3) | 94.57±12.25 | 107.7±13.79 | <0.001* | 131.20±22.32 | 145.73±20.37 | 0.011* | 83.37±11.87 | 93.23±11.70 | 0.002* |
2 min after ECT (T4) | 97.53±12.49 | 111.9±14.10 | <0.001* | 135.00±23.35 | 148.80±21.66 | 0.021* | 85.93±11.96 | 96.40±11.86 | <0.001* |
3 min after ECT (T5) | 93.47±12.23 | 106.4±13.28 | <0.001* | 128.60±21.94 | 144.20±20.65 | 0.006* | 79.80±10.78 | 90.90±10.41 | <0.001* |
5 min after ECT (T6) | 88.77±11.57 | 99.10±12.63 | <0.001* | 124.27±21.44 | 136.93±19.89 | 0.021* | 75.33±10.98 | 84.50±10.29 | <0.001* |
10 min after ECT (T7) | 85.93±11.49 | 91.90±11.41 | 0.048* | 119.78±21.14 | 132.20±19.70 | 0.022* | 73.07±10.91 | 80.27±9.77 | 0.009* |
15 min after ECT (T8) | 84.37±11.85 | 87.70±11.59 | 0.275 | 119.13±21.40 | 133.53±23.04 | 0.015* | 73.00±11.58 | 78.73±9.32 | 0.039* |
30 min after ECT (T9) | 85.27±12.16 | 88.93±12.09 | 0.246 | 125.20±22.88 | 135.87±23.96 | 0.083 | 73.57±11.54 | 80.17±9.91 | 0.021* |
All variables are expressed as mean±SD. Group P received propofol and Group E received etomidate for induction. *P<0.05 is considered statistically significant. SBP=Systolic blood pressure, DBP=Diastolic blood pressure, SD=Standard deviation, ECT=Electroconvulsive therapy